CRON
Cronos Group Inc.
Key Financials
Net Income
$-9447000
↓ 123.0%
Gross Profit
$62.8M
↑ 149.1%
Operating Income
$-17395000
↑ 77.3%
Revenue
$146.6M
↑ 24.6%
EPS (Diluted)
$-0.02
↓ 118.2%
Shareholders' Equity
$1.1B
↑ 2.8%
Total Liabilities
$54.2M
↓ 2.1%
Cash & Equivalents
$791.8M
↓ 7.8%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 8-K | 9/11/2026 | View on SEC |
| 4 | 8/7/2026 | View on SEC |
| 4 | 8/7/2026 | View on SEC |
| 4 | 8/7/2026 | View on SEC |
| 8-K/A | 8/7/2026 | View on SEC |
| 10-Q | 8/6/2026 | View on SEC |
| 8-K | 8/6/2026 | View on SEC |
| 3 | 6/30/2026 | View on SEC |
| 8-K | 6/22/2026 | View on SEC |
| SD | 5/29/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | CRON |
| Company Name | Cronos Group Inc. |
| CIK | 1656472 |
| Sector | Medicinal Chemicals & Botanical Products |
| Industry | Accelerated filer |
| Exchange | Nasdaq |
| SIC Code | 2833 |
| SIC Description | Medicinal Chemicals & Botanical Products |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | A1 |
| Phone | (416) 504-0004 |